BDK advised Mylan in relation to the acquisition of Abbott’s established products business (EPD Business) in Bosnia and Herzegovina, as part of a USD 5.3 billion acquisition of Abbott’s non-U.S. developed markets specialty and branded generics business.
BDK team was led by Partners Vladimir Dašić and Mirjana Mladenović on the corporate law and transactional side and by Ana Jankov on the employment aspects and management relations.
For further information, please contact Aleksandra Yoshida, ayoshida@bdklegal.com, +381 11 3284 212.
